Follow the 동양생명 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Banks sector, 동양생명 has logged 57 reports. The latest transaction was reported on 6 January 2026 (Purchase). Among the most active insiders: 이문구. All data is openly available.
57
Insider Decl.
n/a
Thresholds
n/a
31 ops.
Buy Volume
n/a
4 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Dongyang Life is a South Korean insurance company that provides various life insurance products and financial services. It is listed on the Korea Exchange, XKRX.